Key result
Inpatient 6MWT demonstrates safety with no serious adverse cardiopulmonary effects.
Why the study?
The safety profile of the Six-Minute Walk Test in hospitalized cardiac patients was not well established.
Is the Six-Minute Walk Test safe to perform in hospitalized cardiac patients?
Cross-Sectional (n=30)
Is the Six-Minute Walk Test safe to perform in hospitalized cardiac patients?
This study evaluates the safety and tolerability of the Six-Minute Walk Test in hospitalized cardiac patients.
6MWT safety remains unquantified in hospitalized cardiac patients; larger prospective studies needed before clinical adoption.
This is an observational, cross-sectional, conducted in 30 patients with heart disease who were hospitalized. Two 6MWT practices were carried along a 20-meter corridor. The distance traveled, the cardiorespiratory parameters and signs of intolerance to physical exertion were collected. The adverse effects identified in both practices were classified as non-cardiopulmonary and cardiopulmonary, and in the latter group, divided into non-serious and serious.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2015) conducted a cross-sectional in Hospitalized heart disease (n=30). Six-Minute Walk Test (6MWT) was evaluated on Adverse effects (non-cardiopulmonary and cardiopulmonary), distance traveled, cardiorespiratory parameters, and signs of intolerance to physical exertion. The Six-Minute Walk Test was evaluated for safety and adverse effects in 30 hospitalized cardiac patients, but the abstract reports no quantitative event rates or effect sizes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: